The ESH 3rd Translational Research Conference on Immune & Cellular Therapies takes place on September 13-15, 2024, in Dublin, Ireland, and will focus on Advanced Gene-Engineered Immune Cells. 

The conference co-chaired by T2EVOLVE Project Coordinator Michael Hudecek and partner Chiara Bonini proposes a programme of leading-edge basic and clinical science, as well as opportunities for informal scientific interaction with a panel of global experts in the field.

Abstract submission for the conference is open until July 15, 2024.

Share This